Document ID: chunk:federal_register_of_legislation:F2024L01389:schedule:1:p28
Version: federal_register_of_legislation:F2024L01389
Segment Type: schedule
Provision Reference: sch 1 (pt 28/66)
Character Range: 77234–80307

Schedule 1, Part 1, entry for Methadone in the form Oral liquid containing methadone hydrochloride 25 mg per 5 mL in 200 mL bottle, 1 mL [Brand: Aspen Methadone Syrup; Maximum Quantity: 840; Number of Repeats: 5]
(a) omit from the column headed "Circumstances": C15358  substitute: C16083
(b) omit from the column headed "Purposes": P15358 substitute: P16083
[186] Schedule 1, Part 1, entry for Methadone in the form Oral liquid containing methadone hydrochloride 25 mg per 5 mL in 200 mL bottle, 1 mL [Brand: Biodone Forte]
omit from the column headed "Circumstances": C15358 substitute: C16083
[187] Schedule 1, Part 1, entry for Methadone in the form Tablet containing methadone hydrochloride 10 mg [Maximum Quantity: 20; Number of Repeats: 0]
(a) omit from the column headed "Circumstances": C10745 C10747 C10751 substitute: C15994 C15996 C16000
(b) omit from the column headed "Purposes": P10745 P10747 P10751 substitute: P15994 P15996 P16000
(c) omit from the column headed "Variations": V10745 V10747 V10751 substitute: V15994 V15996 V16000
[188] Schedule 1, Part 1, after entry for Methotrexate in the form Tablet 10 mg [Brand: Chexate; Maximum Quantity: 50; Number of Repeats: 2]
insert:
Methotrexate  Tablet 10 mg  Oral  Methoblastin  PF  MP NP        10  5     10

[189] Schedule 1, Part 1, after entry for Methoxsalen [Maximum Quantity: 12; Number of Repeats: 1]
insert:
Methoxyflurane  Liquid for inhalation 999 mg per g, 3 mL (with inhaler)  Inhalation by mouth  Penthrox (Combination Pack)  DV  See Note 4  See Note 4  See Note 4  See Note 4  See Note 4     1  1  D(MP)

[190] Schedule 1, Part 1, entry for Methoxyflurane (after entry for Methoxy polyethylene glycol-epoetin beta in the form Injection 360 micrograms in 0.6 mL pre-filled syringe)
omit:
Methoxyflurane  Liquid for inhalation 999 mg per g, 3 mL (with inhaler)  Inhalation by mouth  Penthrox  DV  See Note 4  See Note 4  See Note 4  See Note 4  See Note 4     1  1  D(MP)

[191] Schedule 1, Part 1, entries for Metronidazole in the form Tablet 200 mg [Brand: Metrogyl 200]
omit from the column headed "Responsible Person" (all instances): AF  substitute (all instances): XT
[192] Schedule 1, Part 1, entries for Metronidazole in the form Tablet 400 mg [Brand: Metrogyl 400]
omit from the column headed "Responsible Person" (all instances): AF  substitute (all instances): XT
[193] Schedule 1, Part 1, after entry for Morphine in the form Tablet containing morphine sulfate pentahydrate 20 mg [Maximum Quantity: 20; Number of Repeats: 2]
insert:
Morphine  Tablet containing morphine sulfate pentahydrate 30 mg  Oral  Anamorph  RW  MP NP PDP  C10758                                     P10758                                     10  0                                             20
Morphine  Tablet containing morphine sulfate pentahydrate 30 mg  Oral  Anamorph  RW  PDP        C10859                                     P10859                                     20  0                                             20
Morphine  Tablet containing morphine sulfate pentahydrate 30 mg  Oral  Anamorph